First Light Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History

First Light Asset Management, LLC

$1.15 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $15 Million - $19 Million	-450,198 Reduced 77.06%	134,050 $4.95 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $3.15 Million - $4.03 Million	-103,958 Reduced 15.11%	584,248 $21.1 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $7.72 Million - $13.1 Million	-234,913 Reduced 25.45%	688,206 $26.3 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $365,547 - $542,390	-9,125 Reduced 0.98%	923,119 $52.5 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $346,808 - $466,071	-9,001 Reduced 0.96%	932,244 $36.9 Million
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $24.5 Million - $31.7 Million	-656,284 Reduced 41.08%	941,245 $41.4 Million
Q1 2022 May 13, 2022	BUY	$31.97 - $41.06 $2.74 Million - $3.52 Million	85,686 Added 5.67%	1,597,529 $63.7 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1.09 Million - $1.4 Million	34,347 Added 2.32%	1,511,843 $60.8 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $22 Million - $26.6 Million	-572,777 Reduced 27.94%	1,477,496 $60.1 Million
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $1.51 Million - $2 Million	38,923 Added 1.94%	2,050,273 $93.1 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $22.1 Million - $28.8 Million	-560,542 Reduced 21.79%	2,011,350 $83.9 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $17.2 Million - $29 Million	665,103 Added 34.88%	2,571,892 $110 Million
Q3 2020 Nov 13, 2020	BUY	$25.74 - $29.63 $11.5 Million - $13.3 Million	448,244 Added 30.73%	1,906,789 $50.1 Million
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $2.8 Million - $4.61 Million	-172,046 Reduced 10.55%	1,458,545 $39.1 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $975,654 - $1.53 Million	-70,191 Reduced 4.13%	1,630,591 $29.3 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $269,292 - $352,262	18,037 Added 1.07%	1,700,782 $30.2 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $9.35 Million - $10.9 Million	614,932 Added 57.59%	1,682,745 $26.1 Million
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $5.95 Million - $6.97 Million	-403,685 Reduced 27.43%	1,067,813 $18.3 Million
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $7.43 Million - $9.37 Million	533,099 Added 56.81%	1,471,498 $23.7 Million
Q4 2018 Feb 14, 2019	BUY	$13.33 - $18.66 $704,837 - $986,666	52,876 Added 5.97%	938,399 $13.7 Million
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $70,156 - $77,432	-4,206 Reduced 0.47%	885,523 $16.1 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $6.52 Million - $7.85 Million	386,700 Added 76.87%	889,729 $15 Million
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $603,633 - $750,119	35,383 Added 7.57%	503,029 $9.85 Million
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $365,150 - $453,440	21,800 Added 4.89%	467,646 $9.48 Million
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $344,179 - $509,245	29,267 Added 7.03%	445,846 $7.74 Million
Q2 2017 Aug 14, 2017	BUY	N/A	416,579	416,579 $5.34 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Account